Lipsky AH, Lozier JN, Wiestner A. Response to Comment on Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. Haematologica 2016; 101(3):e124-e125; https://doi.org/10.3324/haematol.2015.140558.